E. Obeid, R. Parikh, E. Esterberg, B. Arondekar, A. Hitchens, L. S. Arruda, A. Niyazov
{"title":"摘要PS11-42: HER2晚期乳腺癌(ABC)和种系brca1 /2突变(gBRCA1/2mut)患者的治疗模式和临床结果:来自美国现实世界研究的结果","authors":"E. Obeid, R. Parikh, E. Esterberg, B. Arondekar, A. Hitchens, L. S. Arruda, A. Niyazov","doi":"10.1158/1538-7445.sabcs20-ps11-42","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":20307,"journal":{"name":"Poster Session Abstracts","volume":"21 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Abstract PS11-42: Treatment patterns and clinical outcomes among patients (pts) with HER2- advanced breast cancer (ABC) and germlineBRCA1/2mutation(s) (gBRCA1/2mut): results from a US real-world study\",\"authors\":\"E. Obeid, R. Parikh, E. Esterberg, B. Arondekar, A. Hitchens, L. S. Arruda, A. Niyazov\",\"doi\":\"10.1158/1538-7445.sabcs20-ps11-42\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":20307,\"journal\":{\"name\":\"Poster Session Abstracts\",\"volume\":\"21 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-02-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Poster Session Abstracts\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1158/1538-7445.sabcs20-ps11-42\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Poster Session Abstracts","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1158/1538-7445.sabcs20-ps11-42","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Abstract PS11-42: Treatment patterns and clinical outcomes among patients (pts) with HER2- advanced breast cancer (ABC) and germlineBRCA1/2mutation(s) (gBRCA1/2mut): results from a US real-world study